PolyPid
PYPD
27 hedge funds and large institutions have $4.95M invested in PolyPid in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 2 closing their positions.
292% more call options, than puts
Call options by funds: $686K | Put options by funds: $175K
1% more capital invested
Capital invested by funds: $4.91M → $4.95M (+$37.8K)
0% more funds holding
Funds holding: 27 → 27 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.02% less ownership
Funds ownership: 0.2% → 0.18% (-0.02%)
55% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cerity Partners
New York
|
+$93.4K |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$74.8K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$53.4K |
| 4 |
Morgan Stanley
New York
|
+$28.3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$282K |
| 2 |
Invesco
Atlanta,
Georgia
|
-$101K |
| 3 |
Renaissance Technologies
New York
|
-$72K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$40K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$29.9K |
PYPD Hedge Fund Activity: Q2 2022 in Review
27 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in PolyPid (PYPD) for Q2 2022, worth a combined $4.95M — up 0.77% from $4.91M a quarter earlier.
Fund positioning in PYPD was balanced in Q2 2022: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 11 trimmed.
The largest buyer was Cerity Partners, opening a new position worth an estimated $93.4K. The largest seller was Silverarc Capital Management, cutting an estimated $282K.
- 27 institutional investors held PolyPid (PYPD) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $4.95M of PolyPid stock for Q2 2022, up 0.77% quarter-over-quarter.
- 2 funds opened new PolyPid positions in Q2 2022 and 2 closed out, a net change of 0 holders.
- The largest PolyPid buyer in Q2 2022 was Cerity Partners, an estimated $93.4K added.
- The largest PolyPid seller in Q2 2022 was Silverarc Capital Management, an estimated $282K sold.
Based on aggregated 13F filings for Q2 2022.